Knowles, Simon R. http://orcid.org/0000-0001-8000-1000
Möller, Stephan P.
Stengel, Andreas
Mikocka-Walus, Antonina
Ferreira, Nuno
Trindade, Inês A.
Mokrowiecka, Anna
Burisch, Johan
Barreiro-de Acosta, Manuel
Bernstein, Charles N.
Lo, Bobby
Skvarc, David
Article History
Accepted: 5 January 2023
First Online: 24 January 2023
Change Date: 26 February 2023
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: SRK is an invited speaker at conferences co-organised by Coeliac Australia (a charity) and is a Member of the Medical Advisory Committee for Glutagen Pty Ltd. AS has served as a consultant for A & R Berlin, Boehringer-Ingelheim, Takeda, Medice, Microbiotica and Schwabe. AMW has served as an educational speaker for Janssen and Ferring. IAT has served as a consultant to Pfizer Inc. AM has received lecture fee from PROMED, Alfa-Sigma. JB reports personal fees from AbbVie, personal fees from Janssen-Cilag, personal fees from Celgene, grants and personal fees from MSD, personal fees from Pfizer, grants and personal fees from Takeda, grants and personal fees from Tillots Pharma, personal fees from Samsung Bioepis, grants from Bristol Myers Squibb, grants from Novo Nordisk, personal fees from Pharmacosmos, personal fees from Ferring, outside the submitted work. MBA has served as a speaker, consultant and advisory member for or has received research funding from MSD, AbbVie, Janssen, Kern Pharma, Celltrion, Takeda, Gillead, Celgene, Pfizer, Sandoz, Biogen, Fresenius, Ferring, Faes Farma, Dr. Falk Pharma, Chiesi, Gebro Pharma, Adacyte and Vifor Pharma. CNB has served on advisory boards for Abbvie Canada, Amgen Canada, Avir Pharmaceuticals, Bristol Myers Squibb Canada, Janssen Canada, Pfizer Canada, Roche Canada, Sandoz Canada, Takeda Canada and has consulted to Takeda and Mylan Pharmaceuticals. He has received speaker’s fees from Abbvie Canada, Janssen Canada, Takeda Canada and Pfizer Canada. He has received education grants from Abbvie Canada, Janssen Canada, Pfizer Canada and Takeda Canada and research grants from Abbvie Canada, Pfizer Canada and Takeda Canada. BL has received, outside submitted work, research grant from Tillotts Pharma, and lecture fee from Jassen Cilag. DS has NHMRC support from the Medical Research Future Fund (1200214). SM has no sources of funding and disclosure of interests to declare. NF has no sources of funding and disclosure of interests to declare.<b>Ethical Approval</b>All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Ethical approval for this project was provided by the Swinburne University of Technology Human Research Ethics Committee on 25th May 2020 (Ref: 20202978-4430) and by local ethics committees when required. All participants provided consent to participate.
: All participants provided consent to publish.